Company / Current Liabilities
Edesa Biotech, Inc. Current Liabilities History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$1.5M
FY2021
5-year range
$320.9K / $1.5M
FY2017-FY2021
Trend
-4.7%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $493,385 to $1M over the past 3 years.
Based on SEC 10-K filings.
$1M in FY2021 with a 5-year CAGR of +18.5%.
Increased from $493,385 to $1M over the past 3 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +43.5%
- 5-Year CAGR
- +18.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +18.5%, indicating consistent growth.
- In FY2021, current liabilities decreased 4.7% year-over-year.
- Peak current liabilities was recorded in FY2020.
- Lowest current liabilities in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $1.5M | -4.7% |
| FY2020 | $1.5M | +210.1% |
| FY2018 | $493.4K | +53.7% |
| FY2017 | $320.9K | -48.5% |
| FY2016 | $623.6K | -56.1% |
| FY2015 | $1.4M | +0.0% |
| FY2014 | $1.4M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026